|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,686,408 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$32,096,465 |
|
|
Indirect Value
|
$926,083 |
|
|
Total
Shares |
2,782,875 |
|
|
Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2020-08-07 |
4 |
S |
$125.87 |
$117,185 |
D/D |
(931) |
6,198 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
8,444 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-08-06 |
4 |
S |
$147.96 |
$193,236 |
D/D |
(1,306) |
7,138 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
9,699 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-08-08 |
4 |
S |
$152.32 |
$165,879 |
D/D |
(1,089) |
8,610 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
11,685 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-08-14 |
4 |
S |
$138.16 |
$171,455 |
D/D |
(1,241) |
10,444 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2014-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
57 |
521,638 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
521,581 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-02-20 |
4 |
D |
$19.52 |
$28,890 |
D/D |
(1,480) |
520,158 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-08-14 |
4 |
B |
$11.79 |
$744,421 |
D/D |
63,140 |
583,298 |
2.81 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-08-17 |
4 |
B |
$12.13 |
$204,512 |
D/D |
16,860 |
602,056 |
2.81 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
280,000 |
882,056 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2016-11-20 |
4 |
D |
$31.96 |
$267,186 |
D/D |
(8,360) |
875,399 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
903,399 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-02-20 |
4 |
D |
$33.78 |
$1,123,658 |
D/D |
(33,264) |
870,135 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-05-20 |
4 |
D |
$36.83 |
$569,392 |
D/D |
(15,460) |
856,377 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-08-11 |
4 |
B |
$24.50 |
$245,000 |
D/D |
10,000 |
866,377 |
2.81 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
894,377 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-02-20 |
4 |
D |
$29.09 |
$378,315 |
D/D |
(13,005) |
881,372 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
987,237 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$1,643,769 |
D/D |
(67,617) |
919,620 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-08-20 |
4 |
D |
$26.95 |
$419,261 |
D/D |
(15,557) |
904,063 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-11-20 |
4 |
D |
$24.79 |
$385,658 |
D/D |
(15,557) |
795,939 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
317,000 |
1,112,939 |
0 |
- |
|
130 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|